Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia
Status:
Completed
Trial end date:
2021-08-19
Target enrollment:
Participant gender:
Summary
Explore the efficacy and confirm the safety of the concomitant administration of the standard
of care and hzVSF-v13 in patients with COVID-19 infection